Novartis, Molecular Partners launch trial to test ensovibep as COVID treatment

Novartis, Molecular Partners launch trial to test ensovibep as COVID treatment

Submitted by admin on June 3, 2021 - 12:11am
Source: 
Biopharma Reporter
News Tags: 
Novartis
Molecular Partners
ensovibep
COVID-19
clinical trials
Headline: 
Novartis, Molecular Partners launch trial to test ensovibep as COVID treatment
snippet: 

The EMPHATHY clinical trial will enroll patients with COVID-19 to test the drug’s effectiveness in preventing worsening of symptoms and hospitalization.

Do Not Allow Advertisers to Use My Personal information